*Effects of Icosapent Ethyl on Plasma Ceramides and Coronary Plaque Progression in EVAPORATE trial

Autor: S Lakshmanan, TM Benanzer, J Meeusen, L Donato, DL Bhatt, A Kinninger, I Golub, S Kopecky, MC Hyun, CG Scott, JR Nelson, MJ Budoff, MK Ito, AS Jaffe, VC Vasile

Publikováno v: Journal of Clinical Lipidology. 16:e39

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::597d97e01f6b42585d628a09b93b1bd8
https://doi.org/10.1016/j.jacl.2022.05.013

Association of cardiac biomarkers with long-term cardiovascular events in a community cohort.

Autor: Churchill RA; Mayo Clinic Alix School of Medicine, Rochester, MN, USA., Gochanour BR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Scott CG; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Vasile VC; Department of Cardiovascular Medicine, Wayne and Kathryn Preisel Professor of Cardiovascular Disease Research, Rochester, MN, USA.; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Rodeheffer RJ; Department of Cardiovascular Medicine, Wayne and Kathryn Preisel Professor of Cardiovascular Disease Research, Rochester, MN, USA., Meeusen JW; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Jaffe AS; Department of Cardiovascular Medicine, Wayne and Kathryn Preisel Professor of Cardiovascular Disease Research, Rochester, MN, USA.; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Publikováno v: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2024 Jun; Vol. 29 (4), pp. 161-170. Date of Electronic Publication: 2024 Apr 26.

The Elevated High-Sensitivity Cardiac Troponin T Pilot: Diagnoses and Outcomes.

Autor: Sharain K; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Vasile VC; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Sandoval Y; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Donato LJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Clements CM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Newman JS; Department of Hospital Internal Medicine, Mayo Clinic, Rochester, MN., Karon BS; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Jaffe AS; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. Electronic address: Jaffe.Allan@mayo.edu.

Publikováno v: Mayo Clinic proceedings [Mayo Clin Proc] 2021 Sep; Vol. 96 (9), pp. 2366-2375. Date of Electronic Publication: 2021 May 13.

Ceramide Scores Predict Cardiovascular Risk in the Community.

Autor: Vasile VC; Department of Laboratory Medicine and Pathology (V.C.V., J.W.M., L.J.D., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN.; Department of Cardiovascular Diseases (V.C.V., J.R.M.J., R.R.R., F.L.-J., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN., Meeusen JW; Department of Laboratory Medicine and Pathology (V.C.V., J.W.M., L.J.D., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN., Medina Inojosa JR; Department of Cardiovascular Diseases (V.C.V., J.R.M.J., R.R.R., F.L.-J., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN., Donato LJ; Department of Laboratory Medicine and Pathology (V.C.V., J.W.M., L.J.D., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN., Scott CG; Department of Biomedical Statistics and Informatics (C.G.S., M.S.H.), Mayo Clinic College of Medicine, Rochester, MN., Hyun MS; Department of Biomedical Statistics and Informatics (C.G.S., M.S.H.), Mayo Clinic College of Medicine, Rochester, MN., Vinciguerra M; International Clinical Research Center (ICRC [Human Bridge for Strengthening Integration of ICRC into European Research Area]), St. Anne's University Hospital, Brno, Czech Republic (M.V.)., Rodeheffer RR; Department of Cardiovascular Diseases (V.C.V., J.R.M.J., R.R.R., F.L.-J., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN., Lopez-Jimenez F; Department of Cardiovascular Diseases (V.C.V., J.R.M.J., R.R.R., F.L.-J., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN., Jaffe AS; Department of Laboratory Medicine and Pathology (V.C.V., J.W.M., L.J.D., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN.; Department of Cardiovascular Diseases (V.C.V., J.R.M.J., R.R.R., F.L.-J., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN.

Publikováno v: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2021 Apr; Vol. 41 (4), pp. 1558-1569. Date of Electronic Publication: 2021 Feb 18.

Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors.

Autor: Meeusen JW; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN, United States. Electronic address: meeusen.jeffrey@mayo.edu., Donato LJ; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN, United States., Kopecky SL; Department of Cardiology, Mayo Clinic, Rochester, MN, United States., Vasile VC; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN, United States; Department of Cardiology, Mayo Clinic, Rochester, MN, United States., Jaffe AS; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN, United States; Department of Cardiology, Mayo Clinic, Rochester, MN, United States., Laaksonen R; Zora Biosciences Oy, Espoo, Finland; Finnish Cardiovascular Research Center, Tampere University, Tampere, Finland.

Publikováno v: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2020 Dec; Vol. 511, pp. 138-142. Date of Electronic Publication: 2020 Oct 12.